Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 100 results in range #201 to #300.
- 2,5-Dimethylfuran (1 revision)
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
- 8-cell stage (1 revision)
- 9q34 deletion syndrome (1 revision)
- 8-Aminoquinoline (1 revision)
- 2-Acetylaminofluorene (1 revision)
- 2-Aminoethoxydiphenyl borate (1 revision)
- 2-Aminomuconic acid (1 revision)
- A2ML1 (1 revision)
- ACACA (1 revision)
- A-box 1 of insulin gene (1 revision)
- AAAS (gene) (1 revision)
- 2-Bromopropane (1 revision)
- 2-Butyl-3-(p-tolyl)quinuclidine (1 revision)
- 2-Chlorophenol (1 revision)
- 2-Ethylhexanol (1 revision)
- AADACL4 (1 revision)
- 2-Hydroxyglutaricaciduria (1 revision)
- 2-Iodoxybenzoic acid (1 revision)
- 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene (1 revision)
- 2-Me-DET (1 revision)
- 2-Methyl-2-nitrosopropane (1 revision)
- 2-Methyl-3,3-diphenyl-3-propanolamine (1 revision)
- 2-Methyl-4-Chlorophenoxyacetic Acid (1 revision)
- 2-Methylbutyryl-CoA (1 revision)
- 2-Methylbutyryl-CoA dehydrogenase deficiency (1 revision)
- 2-Nitropropane (1 revision)
- 2-Nonenal (1 revision)
- AARS2 (1 revision)
- 2-Phenylphenol (1 revision)
- 2-Pyridone (1 revision)
- 2-Pyrone (1 revision)
- 2-chloroethanol (1 revision)
- 2-hydroxyphytanoyl-CoA lyase (1 revision)
- ABCA10 (1 revision)
- 2-propanoyl-3-(4-isopropylphenyl)-tropane (1 revision)
- ABCA9 (1 revision)
- ABCC12 (1 revision)
- ABCB11 (1 revision)
- 2007 WikiDoc Foundation Scholars (1 revision)
- 4,5-MDO-DMT (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- 4-Hydroxytestosterone (1 revision)
- ABCC9 (1 revision)
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (1 revision)
- 4-MTA (1 revision)
- 3c syndrome (1 revision)
- 21-Hydroxylase Deficiency (patient information) (1 revision)
- ABRA (gene) (1 revision)
- ABI gene family member 3 (1 revision)
- 4-MeO-MiPT (1 revision)
- 5'-phosphoribosyl-5-aminoimidazole (1 revision)
- ACAA1 (1 revision)
- Ф29 phage (1 revision)
- 5' flanking region (1 revision)
- 5,6-MDO-DiPT (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- 5,6-MeO-MiPT (1 revision)
- 4-Methylbenzylidene camphor (1 revision)
- 5-Hydroxyindoleacetic acid (1 revision)
- 4-Nitroaniline (1 revision)
- 5-alpha-reductase deficiency primary prevention (1 revision)
- 4-Methylthioamphetamine (1 revision)
- 5-MeO-DET (1 revision)
- 5-MeO-DALT (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- 4-Chloroindole-3-acetic acid (1 revision)
- 5-MeO-pyr-T (1 revision)
- 4-Oxalocrotonate tautomerase (1 revision)
- 40S (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 4-Dimethylaminophenol (1 revision)
- 5-Methylindole (1 revision)
- 5-Methylcytosine (1 revision)
- 5-bromouracil (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 60S ribosomal protein L28 (1 revision)
- 60S ribosomal protein L17 (1 revision)
- 2C-D (1 revision)
- 60S ribosomal protein L7a (1 revision)
- 40S ribosomal protein S13 (1 revision)
- 60S ribosomal protein L26 (1 revision)
- 4-HO-DET (1 revision)
- 3C-P (1 revision)
- 5150 (Involuntary psychiatric hold) (1 revision)
- 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
- 3-Aminoisobutyric acid (1 revision)
- 4-HO-pyr-T (1 revision)
- 5-hydroxytryptophan (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- 60S ribosomal protein L30 (1 revision)
- 3-Aminopyridine (1 revision)
- 4-HO-MPT (1 revision)
- 22q11.2 deletion syndrome case study one (1 revision)
- ABCC4 (1 revision)
- 5-MeS-DMT (1 revision)
- 23andMe (1 revision)
- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
- 5-alpha-reductase deficiency secondary prevention (1 revision)
- 310 helix (1 revision)